Market Cap 394.14B
Revenue (ttm) 56.33B
Net Income (ttm) 4.28B
EPS (ttm) N/A
PE Ratio 23.33
Forward PE 15.39
Profit Margin 7.59%
Debt to Equity Ratio -26.45
Volume 5,412,900
Avg Vol 6,187,084
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 77%
Beta 0.36
Analysts Strong Sell
Price Target $245.80

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 847 932 7900
Address:
1 North Waukegan Road, North Chicago, United States
koditrump
koditrump Feb. 2 at 5:59 PM
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Feb. 2 at 5:22 PM
$LXRX A more perfect timeline could not have happened to us: 1. Jan 21st : FDA approved phase 3 Pilavapadin. 2. Jan 27-29 FIREST EVER: INAUGURAL ( meaning this will be a yearly event -quite historical in my view ) : Non-Opioid Pain Therapeutic Summit with $VRTX , $LLY $ABBV and other heavey hitters. 3. On the LAST DAY of the Summit, $LXRX responsibly tells of of their plans for liquidity. Then LATER on that same date, 13 hours later, after hours, we discover, exactly how much. A better timeline cannot exist. It just cannot.
0 · Reply
ZacksResearch
ZacksResearch Feb. 2 at 4:36 PM
$ABBV set for Q4 earnings — will Skyrizi & Rinvoq drive growth? 💊 🔹 Zacks Consensus Estimate for Q4 sales is $16.36B with EPS of $2.66 🔹 Skyrizi & Rinvoq sales projected at $4.91B & $2.39B, respectively 🔹 Humira's downward trend due to biosimilars continues Discover if ABBV is a long-term buy here 👉 https://www.zacks.com/stock/news/2827163/buy-abbvie-stock-before-q4-earnings-heres-what-to-know?cid=sm-stocktwits-2-2827163-body-31494&ADID=SYND_STOCKTWITS_TWEET_2_2827163_BODY_31494
0 · Reply
HydrogenH2
HydrogenH2 Feb. 2 at 3:36 PM
$ABBV Time to take some $$$
0 · Reply
ZacksResearch
ZacksResearch Feb. 2 at 3:36 PM
$ABBV ahead of Q4 earnings — growth engines vs. legacy pressure ⚖️ Skyrizi and Rinvoq are driving growth as Humira sales continue to slide, with shares trading at a discount to the industry heading into the quarter. What really matters before the print 👉 https://www.zacks.com/stock/news/2827163/buy-abbvie-stock-before-q4-earnings-heres-what-to-know?cid=sm-stocktwits-2-2827163-teaser-31482&ADID=SYND_STOCKTWITS_TWEET_2_2827163_TEASER_31482
0 · Reply
Czreri1
Czreri1 Feb. 2 at 3:27 PM
$ABBV same thing everyday pump in the first 30 and then sell off
0 · Reply
taxplanr
taxplanr Feb. 2 at 3:09 PM
Ivermectin treating Cancer has become well known but now it's treating Rheumatoid Arthritis $ABBV https://makisw.substack.com/p/ivermectin-fenbendazole-and-dmso?utm_source=post-email-title&publication_id=1385328&post_id=186452168&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
koditrump
koditrump Feb. 2 at 1:08 PM
$ABBV $ABNB $ALGN $TSLA $WYNN Good Morning!! ⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️
0 · Reply
HalfTrader
HalfTrader Feb. 1 at 7:30 PM
0 · Reply
dewmoore
dewmoore Feb. 1 at 1:19 PM
$SLS Happy February 1: The 'Godzilla' Math is officially locked. 🦖📈 Enrollment ended April '24. We are now at 22 MONTHS—officially beating the Phase 2 record. Since only 72 have died, the only way we fail is if the other 54 died over the weekend. Spoilers: THEY DIDN'T! The IDMC is in the hot seat this week or next week! Under the new Jan '26 FDA rules, if they see this 'overwhelming' efficacy (likely a 63:9 split), they MUST recommend stoppage. Ignoring this creates a massive legal liability & standard-of-care trap! The shorts are trapped in a 42M share hole with the 'Death Clock' stopped. This is our month. $SLS #AML #GPS #ShortSqueeze $ATYR $MRK $ABBV If you have NOT read this on REDDIT -- you should on your Sunday DD -- Let's make a lot of money gang!!!!!! https://www.reddit.com/r/TheRaceTo10Million/comments/1qsbg5l/sls_to_crown_hundreds_of_millionaires_in_february/
4 · Reply
Latest News on ABBV
Best Dividend Kings: January 2026

Jan 25, 2026, 10:11 PM EST - 8 days ago

Best Dividend Kings: January 2026

ABM ABT ADM ADP AWR BDX BKH


AbbVie plans to build out its presence in obesity market

Jan 14, 2026, 2:01 PM EST - 19 days ago

AbbVie plans to build out its presence in obesity market


Abbvie, US reach agreement to cut drug prices

Jan 12, 2026, 6:57 PM EST - 21 days ago

Abbvie, US reach agreement to cut drug prices


AbbVie, RemeGen partner on experimental solid tumor treatment

Jan 12, 2026, 7:39 AM EST - 21 days ago

AbbVie, RemeGen partner on experimental solid tumor treatment


Dividend Income: Lanny's November 2025 Summary

Jan 12, 2026, 5:12 AM EST - 21 days ago

Dividend Income: Lanny's November 2025 Summary

AFL CAT COF CVS CZNC EMR ETN


MoneyShow's Best Investment Ideas For 2026: Part 1

Jan 10, 2026, 9:30 AM EST - 23 days ago

MoneyShow's Best Investment Ideas For 2026: Part 1

ABR ACHR ARE ARES ARMN ASTS


AbbVie: The Dividend Does Not Lie

Jan 8, 2026, 12:07 PM EST - 25 days ago

AbbVie: The Dividend Does Not Lie


AbbVie Near Deal for Revolution Medicines

Jan 7, 2026, 2:48 PM EST - 26 days ago

AbbVie Near Deal for Revolution Medicines

RVMD


What Can Trigger A Breakout In Abbvie Stock?

Jan 6, 2026, 11:43 AM EST - 27 days ago

What Can Trigger A Breakout In Abbvie Stock?


AbbVie: Rocky Near-Term, Positive Long-Term

Jan 4, 2026, 9:04 AM EST - 4 weeks ago

AbbVie: Rocky Near-Term, Positive Long-Term


Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 4 weeks ago

Best Dividend Aristocrats For January 2026

ABT ADM ADP AFL ALB AMCR AOS


Best Dividend Kings: December 2025

Dec 28, 2025, 6:44 AM EST - 5 weeks ago

Best Dividend Kings: December 2025

ABM ABT ADM ADP AWR BDX BKH


Trump to announce new drug-pricing deals later today

Dec 19, 2025, 10:45 AM EST - 6 weeks ago

Trump to announce new drug-pricing deals later today

AMGN AZN BMY GILD LLY MRK NVO


AbbVie: Unique Mix Of Growth And Value

Dec 10, 2025, 8:01 PM EST - 7 weeks ago

AbbVie: Unique Mix Of Growth And Value


Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 2 months ago

Best Dividend Aristocrats For December 2025

ABT ADM ADP AFL ALB AMCR AOS


koditrump
koditrump Feb. 2 at 5:59 PM
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Feb. 2 at 5:22 PM
$LXRX A more perfect timeline could not have happened to us: 1. Jan 21st : FDA approved phase 3 Pilavapadin. 2. Jan 27-29 FIREST EVER: INAUGURAL ( meaning this will be a yearly event -quite historical in my view ) : Non-Opioid Pain Therapeutic Summit with $VRTX , $LLY $ABBV and other heavey hitters. 3. On the LAST DAY of the Summit, $LXRX responsibly tells of of their plans for liquidity. Then LATER on that same date, 13 hours later, after hours, we discover, exactly how much. A better timeline cannot exist. It just cannot.
0 · Reply
ZacksResearch
ZacksResearch Feb. 2 at 4:36 PM
$ABBV set for Q4 earnings — will Skyrizi & Rinvoq drive growth? 💊 🔹 Zacks Consensus Estimate for Q4 sales is $16.36B with EPS of $2.66 🔹 Skyrizi & Rinvoq sales projected at $4.91B & $2.39B, respectively 🔹 Humira's downward trend due to biosimilars continues Discover if ABBV is a long-term buy here 👉 https://www.zacks.com/stock/news/2827163/buy-abbvie-stock-before-q4-earnings-heres-what-to-know?cid=sm-stocktwits-2-2827163-body-31494&ADID=SYND_STOCKTWITS_TWEET_2_2827163_BODY_31494
0 · Reply
HydrogenH2
HydrogenH2 Feb. 2 at 3:36 PM
$ABBV Time to take some $$$
0 · Reply
ZacksResearch
ZacksResearch Feb. 2 at 3:36 PM
$ABBV ahead of Q4 earnings — growth engines vs. legacy pressure ⚖️ Skyrizi and Rinvoq are driving growth as Humira sales continue to slide, with shares trading at a discount to the industry heading into the quarter. What really matters before the print 👉 https://www.zacks.com/stock/news/2827163/buy-abbvie-stock-before-q4-earnings-heres-what-to-know?cid=sm-stocktwits-2-2827163-teaser-31482&ADID=SYND_STOCKTWITS_TWEET_2_2827163_TEASER_31482
0 · Reply
Czreri1
Czreri1 Feb. 2 at 3:27 PM
$ABBV same thing everyday pump in the first 30 and then sell off
0 · Reply
taxplanr
taxplanr Feb. 2 at 3:09 PM
Ivermectin treating Cancer has become well known but now it's treating Rheumatoid Arthritis $ABBV https://makisw.substack.com/p/ivermectin-fenbendazole-and-dmso?utm_source=post-email-title&publication_id=1385328&post_id=186452168&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
koditrump
koditrump Feb. 2 at 1:08 PM
$ABBV $ABNB $ALGN $TSLA $WYNN Good Morning!! ⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️
0 · Reply
HalfTrader
HalfTrader Feb. 1 at 7:30 PM
0 · Reply
dewmoore
dewmoore Feb. 1 at 1:19 PM
$SLS Happy February 1: The 'Godzilla' Math is officially locked. 🦖📈 Enrollment ended April '24. We are now at 22 MONTHS—officially beating the Phase 2 record. Since only 72 have died, the only way we fail is if the other 54 died over the weekend. Spoilers: THEY DIDN'T! The IDMC is in the hot seat this week or next week! Under the new Jan '26 FDA rules, if they see this 'overwhelming' efficacy (likely a 63:9 split), they MUST recommend stoppage. Ignoring this creates a massive legal liability & standard-of-care trap! The shorts are trapped in a 42M share hole with the 'Death Clock' stopped. This is our month. $SLS #AML #GPS #ShortSqueeze $ATYR $MRK $ABBV If you have NOT read this on REDDIT -- you should on your Sunday DD -- Let's make a lot of money gang!!!!!! https://www.reddit.com/r/TheRaceTo10Million/comments/1qsbg5l/sls_to_crown_hundreds_of_millionaires_in_february/
4 · Reply
crtlabz
crtlabz Feb. 1 at 2:53 AM
$ABBV pipeline and growth accelerating. Been here 17y and don't mind the income. Divvy could be better, but better fundementals are the focus.
1 · Reply
DM1963
DM1963 Jan. 31 at 6:44 PM
$ABBV Wow this stock was 60 during Covid expectations high would be nice to see them lower
0 · Reply
JFDI
JFDI Jan. 30 at 8:44 PM
0 · Reply
ChessGM
ChessGM Jan. 30 at 7:59 PM
$ABBV https://youtu.be/h-s8MagQo1k. My focus list for stocks reporting earnings next week.
0 · Reply
taxplanr
taxplanr Jan. 30 at 5:49 PM
$ABBV not a bad yield for $110
0 · Reply
Sunny3999
Sunny3999 Jan. 30 at 2:10 PM
$PMN fast track designation and DSMB approval and with this news $175 MILLION in the pocket ready to fly 🛫🚀 https://www.promisneurosciences.com/news-media/press-releases/detail/261/promis-neurosciences-announces-up-to-175-million-private $ABBV $CELG $JNJ $PFE
0 · Reply
Sunny3999
Sunny3999 Jan. 30 at 1:13 PM
$PMN Boom 💥 News with news $175 million private placement https://www.promisneurosciences.com/news-media/press-releases/detail/261/promis-neurosciences-announces-up-to-175-million-private $ABBV $BMY $MRK $SNY
0 · Reply
dogDazeSummer
dogDazeSummer Jan. 29 at 10:55 PM
$MLTX $IFRX The future kings of HS both looking tired of dropping. Exhausted sellers and now time to decide which BP is gonna gobble. 2 very important and completely independent MOA’s, no winner takes all with this sneaky disease. $ABBV $PFE $MRK
1 · Reply
scottybebs
scottybebs Jan. 29 at 9:15 PM
$ABBV what was that close!?
1 · Reply
Buster67
Buster67 Jan. 29 at 6:30 PM
$ABBV Sellers showing hesitation
0 · Reply
clan
clan Jan. 29 at 5:03 AM
$NVS $ABBV $RHHBY Who here knew there is an INHALABLE mealtime insulin?!? Holy smokes! 😲 No shooting up at meals! ❤️
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Jan. 28 at 9:45 PM
$ABBV Trading around $220, bouncing off recent lows near $170. Bulls struggling to break above $245 resistance level in the past. Volume showing some decline in recent sessions.
0 · Reply